QURE
Uniqure NV
Price:  
13.70 
USD
Volume:  
1,614,108.00
Netherlands | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

QURE WACC - Weighted Average Cost of Capital

The WACC of Uniqure NV (QURE) is 10.8%.

The Cost of Equity of Uniqure NV (QURE) is 11.65%.
The Cost of Debt of Uniqure NV (QURE) is 9.50%.

Range Selected
Cost of equity 10.20% - 13.10% 11.65%
Tax rate 1.00% - 1.10% 1.05%
Cost of debt 7.00% - 12.00% 9.50%
WACC 8.9% - 12.6% 10.8%
WACC

QURE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.38 1.47
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.20% 13.10%
Tax rate 1.00% 1.10%
Debt/Equity ratio 0.65 0.65
Cost of debt 7.00% 12.00%
After-tax WACC 8.9% 12.6%
Selected WACC 10.8%

QURE's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for QURE:

cost_of_equity (11.65%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (1.38) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.